To investigate whether a complete suppression of eEF2 phosphorylation could alleviate AD pathophysiology, a genetic approach was used to knockout eEF2K completely in AD by crossing the eEF2K ± mice with APP/eEF2K ± mice as described in the method section. This evidence concerns the gene EEF2K and Alzheimer disease.